The Lysophosphatidic Acid Type 2 Receptor Is Required for Protection Against Radiation-Induced Intestinal Injury
Open Access
- 1 May 2007
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 132 (5), 1834-1851
- https://doi.org/10.1053/j.gastro.2007.03.038
Abstract
No abstract availableKeywords
Funding Information
- U.S. Public Health Service (HL61469)
This publication has 61 references indexed in Scilit:
- Supervillin modulation of focal adhesions involving TRIP6/ZRP-1The Journal of cell biology, 2006
- The ins and outs of lysophosphatidic acid signalingBioEssays, 2004
- Up-regulation of interleukin-6 in human ovarian cancer cell via a Gi/PI3K-Akt/NF- B pathway by lysophosphatidic acid, an ovarian cancer-activating factorCarcinogenesis: Integrative Cancer Research, 2004
- Identification of p2y9/GPR23 as a Novel G Protein-coupled Receptor for Lysophosphatidic Acid, Structurally Distant from the Edg FamilyJournal of Biological Chemistry, 2003
- Regulation of BAD phosphorylation at serine 112 by the Ras-mitogen-activated protein kinase pathwayOncogene, 1999
- Soy‐derived antiapoptotic fractions protect gastrointestinal epithelium from damage caused by methotrexate treatment in the ratNutrition and Cancer, 1999
- A soy‐derived antiapoptotic fraction decreases methotrexate toxicity in the gastrointestinal tract of the ratNutrition and Cancer, 1997
- Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94Journal of Computational Chemistry, 1996
- Apoptosis and gastrointestinal pharmacologyPharmacology & Therapeutics, 1996
- Metabolic conversion of the biologically active phospholipid, lysophosphatidic acid, in fibroblastsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1992